SAB Biotherapeutics (SABS) EBIT (2021 - 2026)
SAB Biotherapeutics (SABS) reported EBIT of -$23.38 million for Q2 2026, compared with -$9.73 million a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) EBIT (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' EBIT came in at -$71.82 million; for FY2025, it came in at -$48.95 million.
- By year, EBIT came in at -$42.91 million in FY2024, -$38.08 million in FY2023, -$28.92 million in FY2022 and -$13.39 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBIT in data going back to Q1 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$20 million (Q1 2026), -$15.77 million (Q4 2025) and -$12.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | SAB Biotherapeutics | 223.71 Mn | -193.79 Mn | - | -23.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.38 Mn |
| Mar 31, 2026 | -20.00 Mn |
| Dec 31, 2025 | -15.77 Mn |
| Sep 30, 2025 | -12.68 Mn |
| Jun 30, 2025 | -9.73 Mn |
| Mar 31, 2025 | -10.77 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -11.31 Mn |
| Jun 30, 2024 | -10.20 Mn |
| Mar 31, 2024 | -11.39 Mn |
| Dec 31, 2023 | -18.87 Mn |
| Sep 30, 2023 | -5.32 Mn |
| Jun 30, 2023 | -6.48 Mn |
| Mar 31, 2023 | -7.40 Mn |
| Dec 31, 2022 | -7.86 Mn |
| Sep 30, 2022 | -7.81 Mn |
| Jun 30, 2022 | -6.54 Mn |
| Mar 31, 2022 | -6.71 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Sep 30, 2021 | -3.99 Mn |
API Access
SAB Biotherapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();